<DOC>
	<DOC>NCT03079466</DOC>
	<brief_summary>Objective: To analyze the impact of CPAP treatment on cognitive, clinical and quality of life domains in patients over 70 years of age with mild-to-moderate OSA Primary Outcome: Epworth scale and QSQ domains Secondary Outcomes: Neurocognitive variables and CPAP adherence</brief_summary>
	<brief_title>Effect of CPAP Treatment on the Elderly With Mild to Moderate Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>Age equal or greater than 70 years of both sexes Patients with sleep study results with AHI ≥ 15 and &lt; 30 Alternative diagnoses of other nonrespiratory sleep disorders that are also cause of pathological somnolence (eg, sdr restless legs, narcolepsy, etc.) Don't sign informed consent Acute or chronic respiratory insufficiency requiring home oxygen therapy Patients with Obesity Hypoventilation Syndrome Diagnosis of neuropsychiatric diseases with the exception of anxiety depression or diagnosis of dementia. Diseases of any origin in the acute phase Heart failure or recent stroke (less than 3 months). Central SAHS (more than 50% of the registry with central apneas or CheyneStokes breathing) Pretreatment with CPAP Inability to perform the diagnostic study of sleep due to the patient's condition Hipersomniaincapacitante (Epworth≥18) with no known or most likely cause related to SAHS</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Sleep apnea</keyword>
	<keyword>Elderly</keyword>
	<keyword>CPAP</keyword>
</DOC>